Patents by Inventor Xiubin Liang

Xiubin Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF SGLT-1 AND USES THEREOF
    Publication number: 20240148764
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical agents which function as inhibitors of sodium-glucose cotransporter 1 (SGLT-1) activity. The invention further relates to methods of treating and/or ameliorating symptoms related to cystic fibrosis-related liver disease and diseases characterized with increased SGLT-1 activity, increased endoplasmic reticulum (ER) stress response, and/or increased hepatic inflammation.
    Type: Application
    Filed: March 4, 2022
    Publication date: May 9, 2024
    Inventors: Jie Xu, Kezhong Zhang, Xiubin Liang, Yuqing Eugene Chen
  • INHIBITORS OF SGLT AND USES THEREOF
    Publication number: 20220323400
    Abstract: This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical agents which function as inhibitors of sodium-glucose cotransporter (SGLT) activity. The invention further relates to methods of treating and/or ameliorating symptoms related to cystic fibrosis (CF), comprising administering to a subject (e.g., a human patient) a composition comprising one or more pharmaceutical agents which function as inhibitors of SGLT activity.
    Type: Application
    Filed: September 4, 2020
    Publication date: October 13, 2022
    Inventors: Yuqing Chen, Jifeng Zhang, Jie Xu, Xiubin Liang, Jian-Ping Jin, Fei Sun